148 related articles for article (PubMed ID: 35865938)
61. Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey.
Zeiser R; Burchert A; Lengerke C; Verbeek M; Maas-Bauer K; Metzelder SK; Spoerl S; Ditschkowski M; Ecsedi M; Sockel K; Ayuk F; Ajib S; de Fontbrune FS; Na IK; Penter L; Holtick U; Wolf D; Schuler E; Meyer E; Apostolova P; Bertz H; Marks R; Lübbert M; Wäsch R; Scheid C; Stölzel F; Ordemann R; Bug G; Kobbe G; Negrin R; Brune M; Spyridonidis A; Schmitt-Gräff A; van der Velden W; Huls G; Mielke S; Grigoleit GU; Kuball J; Flynn R; Ihorst G; Du J; Blazar BR; Arnold R; Kröger N; Passweg J; Halter J; Socié G; Beelen D; Peschel C; Neubauer A; Finke J; Duyster J; von Bubnoff N
Leukemia; 2015 Oct; 29(10):2062-8. PubMed ID: 26228813
[TBL] [Abstract][Full Text] [Related]
62. NHANES III equations enhance early detection and mortality prediction of bronchiolitis obliterans syndrome after hematopoietic SCT.
Williams KM; Hnatiuk O; Mitchell SA; Baird K; Gadalla SM; Steinberg SM; Shelhamer J; Carpenter A; Avila D; Taylor T; Grkovic L; Pulanic D; Comis LE; Blacklock-Schuver B; Gress RE; Pavletic SZ
Bone Marrow Transplant; 2014 Apr; 49(4):561-6. PubMed ID: 24419526
[TBL] [Abstract][Full Text] [Related]
63. Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study.
Escamilla Gómez V; García-Gutiérrez V; López Corral L; García Cadenas I; Pérez Martínez A; Márquez Malaver FJ; Caballero-Velázquez T; González Sierra PA; Viguria Alegría MC; Parra Salinas IM; Calderón Cabrera C; González Vicent M; Rodríguez Torres N; Parody Porras R; Ferra Coll C; Orti G; Valcárcel Ferreiras D; De la Cámara LLanzá R; Molés P; Velázquez-Kennedy K; João Mende M; Caballero Barrigón D; Pérez E; Martino Bofarull R; Saavedra Gerosa S; Sierra J; Poch M; Zudaire Ripa MT; Díaz Pérez MA; Molina Angulo B; Sánchez Ortega I; Sanz Caballer J; Montoro Gómez J; Espigado Tocino I; Pérez-Simón JA;
Bone Marrow Transplant; 2020 Mar; 55(3):641-648. PubMed ID: 31700138
[TBL] [Abstract][Full Text] [Related]
64. Ruxolitinib in steroid refractory graft-vs.-host disease: a case report.
Maffini E; Giaccone L; Festuccia M; Brunello L; Buondonno I; Ferrero D; Boccadoro M; Dellacasa C; Busca A; Novero D; Bruno B
J Hematol Oncol; 2016 Aug; 9(1):67. PubMed ID: 27502249
[TBL] [Abstract][Full Text] [Related]
65. Early Post-Transplantation Spirometry Is Associated with the Development of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplantation.
Jamani K; He Q; Liu Y; Davis C; Hubbard J; Schoch G; Lee SJ; Gooley T; Flowers MED; Cheng GS
Biol Blood Marrow Transplant; 2020 May; 26(5):943-948. PubMed ID: 31821885
[TBL] [Abstract][Full Text] [Related]
66. Therapeutic effect of budesonide/formoterol, montelukast and N-acetylcysteine for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
Kim SW; Rhee CK; Kim YJ; Lee S; Kim HJ; Lee JW
Respir Res; 2016 May; 17(1):63. PubMed ID: 27229850
[TBL] [Abstract][Full Text] [Related]
67. Diagnosis of Post-Hematopoietic Stem Cell Transplantation Bronchiolitis Obliterans Syndrome in Children: Time for a Rethink?
Shanthikumar S; Gower WA; Cooke KR; Bergeron A; Schultz KR; Barochia A; Tamae-Kakazu M; Charbek E; Reardon EE; Calvo C; Casey A; Cheng PC; Cole TS; Davies SM; Das S; De A; Deterding RR; Liptzin DR; Mechinaud F; Rayment JH; Robinson PD; Siddaiah R; Stone A; Srinivasin S; Towe CT; Yanik GA; Iyer NP; Goldfarb SB
Transplant Cell Ther; 2024 Jun; ():. PubMed ID: 38897861
[TBL] [Abstract][Full Text] [Related]
68. Effects of azithromycin in bronchiolitis obliterans syndrome after hematopoietic SCT--a randomized double-blinded placebo-controlled study.
Lam DC; Lam B; Wong MK; Lu C; Au WY; Tse EW; Leung AY; Kwong YL; Liang RH; Lam WK; Ip MS; Lie AK
Bone Marrow Transplant; 2011 Dec; 46(12):1551-6. PubMed ID: 21317934
[TBL] [Abstract][Full Text] [Related]
69. Airway dilation in bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.
Gazourian L; Coronata AM; Rogers AJ; Weinhouse GL; Soiffer RJ; Antin JH; Ritz J; Ho VT; Baron RM; Washko GR
Respir Med; 2013 Feb; 107(2):276-83. PubMed ID: 23195332
[TBL] [Abstract][Full Text] [Related]
70. Calcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantation.
Hostettler KE; Halter JP; Gerull S; Lardinois D; Savic S; Roth M; Tamm M
Eur Respir J; 2014 Jan; 43(1):221-32. PubMed ID: 23645405
[TBL] [Abstract][Full Text] [Related]
71. Comprehensive pulmonary rehabilitation in patients with bronchiolitis obliterans syndrome: A case series.
Choi HE; Lim SN; Lee JH; Park SH
Respir Med Case Rep; 2020; 31():101161. PubMed ID: 32695572
[TBL] [Abstract][Full Text] [Related]
72. Tracheobronchomalacia following allogeneic haematopoietic stem cell transplantation.
Panpruang P; Eksombatchai D; Boonsarngsuk V
Respirol Case Rep; 2024 May; 12(5):e01348. PubMed ID: 38690063
[TBL] [Abstract][Full Text] [Related]
73. Ruxolitinib is an effective steroid sparing agent in children with steroid refractory/dependent bronchiolitis obliterans syndrome after allogenic hematopoietic cell transplantation.
Schoettler M; Duncan C; Lehmann L; Furutani E; Subramaniam M; Margossian S
Bone Marrow Transplant; 2019 Jul; 54(7):1158-1160. PubMed ID: 30683905
[No Abstract] [Full Text] [Related]
74. Impact of Lung Function on Bronchiolitis Obliterans Syndrome and Outcome after Allogeneic Hematopoietic Cell Transplantation with Reduced-Intensity Conditioning.
Duque-Afonso J; Ihorst G; Waterhouse M; Zeiser R; Wäsch R; Bertz H; Müller-Quernheim J; Finke J; Marks R; Prasse A
Biol Blood Marrow Transplant; 2018 Nov; 24(11):2277-2284. PubMed ID: 29964193
[TBL] [Abstract][Full Text] [Related]
75. Lung Function Trajectory in Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplant.
Cheng GS; Storer B; Chien JW; Jagasia M; Hubbard JJ; Burns L; Ho VT; Pidala J; Palmer J; Johnston L; Mayer S; Crothers K; Pusic I; Lee SJ; Williams KM
Ann Am Thorac Soc; 2016 Nov; 13(11):1932-1939. PubMed ID: 27513368
[TBL] [Abstract][Full Text] [Related]
76. Characterization of localized macrophages in bronchiolitis obliterans after allogeneic hematopoietic cell transplantation.
Kuroi T; Fujii N; Ichimura K; Seike K; Yamamoto A; Kambara Y; Sugimoto S; Otani S; Saeki K; Fujiwara H; Nishiomori H; Oto T; Maeda Y
Int J Hematol; 2021 Dec; 114(6):701-708. PubMed ID: 34494183
[TBL] [Abstract][Full Text] [Related]
77. Successful ruxolitinib administration for a patient with steroid-refractory idiopathic pneumonia syndrome following hematopoietic stem cell transplantation: A case report and literature review.
Tomomasa D; Isoda T; Mitsuiki N; Yamashita M; Morishita A; Tomoda T; Okano T; Endo A; Kamiya T; Yanagimachi M; Imai K; Kanegane H; Takagi M; Morio T
Clin Case Rep; 2021 Dec; 9(12):e05242. PubMed ID: 34987813
[TBL] [Abstract][Full Text] [Related]
78. Peritransplantation Ruxolitinib Prevents Acute Graft-versus-Host Disease in Patients with Myelofibrosis Undergoing Allogenic Stem Cell Transplantation.
Kröger N; Shahnaz Syed Abd Kadir S; Zabelina T; Badbaran A; Christopeit M; Ayuk F; Wolschke C
Biol Blood Marrow Transplant; 2018 Oct; 24(10):2152-2156. PubMed ID: 29800615
[TBL] [Abstract][Full Text] [Related]
79. Ruxolitinib-corticosteroid as first-line therapy for newly diagnosed high-risk acute graft versus host disease: study protocol for a multicenter, randomized, phase II controlled trial.
Dou L; Peng B; Li X; Wang L; Jia M; Xu L; Li F; Liu D
Trials; 2022 Jun; 23(1):470. PubMed ID: 35668528
[TBL] [Abstract][Full Text] [Related]
80. Steroid-sparing effect of extracorporeal photopheresis in the therapy of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Ussowicz M; Musiał J; Mielcarek M; Tomaszewska A; Nasiłowska-Adamska B; Kałwak K; Gorczyńska E; Mariańska B; Chybicka A
Transplant Proc; 2013 Nov; 45(9):3375-80. PubMed ID: 24182819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
